Bryan Stuart Email & Phone

Chief Executive Officer @ Fulcrum Therapeutics

@ Atavistik Bio

Chief Operating Officer @ Fulcrum Therapeutics

President and CEO @ Yarra Therapeutics

President and CEO @ Kastle Therapeutics

Chief Business Officer @ Civitas Therapeutics

Chief of Corporate Development @ EKR Therapeutics

Vice President of Business Development, Corporate Development and Strategy @ Ovation Pharmaceuticals/ Lundbeck (acquirer of Ovation)

Analyst @ William Blair

- @ Northwestern University - Kellogg School of Management

- @ University of Illinois Urbana-Champaign

Pharmaceuticals, Biotechnology, Mergers, Executive Management, Strategic Planning, Development Strategy, Corporate Strategy Formulation, Licensing, life science, M&A experience, Acquisition Integration, Venture Capital, Healthcare, Corporate Finance, Strategic Partnerships, Strategy, Mergers & Acquisitions, Business Development, Corporate Development, Pharmaceutical Industry, Biopharmaceuticals, Medical Devices, Lifesciences, Life Sciences, Mergers and Acquisitions, Microsoft Excel, Marketing, Customer Service, Financial Reporting, SQL, Leadership, Sales, Microsoft Office

Bryan Stuart, based in Boston, MA, US, is currently a Chief Executive Officer at Fulcrum Therapeutics. Bryan Stuart brings experience from previous roles at Atavistik Bio, Fulcrum Therapeutics, Yarra Therapeutics, Kastle Therapeutics, Civitas Therapeutics, EKR Therapeutics, Ovation Pharmaceuticals/ Lundbeck (acquirer of Ovation), William Blair. Bryan Stuart holds various educational qualifications from Northwestern University - Kellogg School of Management. With a robust skill set that includes Pharmaceuticals, Biotechnology, Mergers, Executive Management, Strategic Planning, Bryan Stuart demonstrates proficiency in a wide range of areas.